-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Overweight on OPKO Health, Raises Price Target to $4

Benzinga·10/16/2026 17:09:11
语音播报
Piper Sandler analyst Edward Tenthoff reiterates OPKO Health (NASDAQ:OPK) with a Overweight and raises the price target from $3 to $4.